Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
410 Medical has raised $12 million in financing led by Orlando Health Ventures, with funds aimed at expanding commercial operations and launching the next version of its LifeFlow infuser in 2027.
Mission North has expanded its Health practice after achieving 33 percent year-over-year growth and appointed Alex Hunter as Executive Vice President of Health and Innovation. The move deepens the agency’s focus on healthcare, technology, and AI integration.
Newronika has received CE Mark certification for its adaptive deep brain stimulation system αDBS, which is now commercially approved across the European Economic Area and fully integrated with the company’s WebBioBank neural data platform.
ORTEC has acquired TOBA HR Solutions, a provider of workforce management software in Belgium and Luxembourg, expanding its healthcare customer base to over 250 organizations and 225,000 professionals.
RWS has introduced a new eCOA translation and linguistic validation service aimed at reducing delays in global clinical trials by combining licensing, translation, migration, and rater training under one unified program team.
Filevine has partnered with Codes Health to integrate AI based medical record retrieval directly into its legal work platform, accelerating record access for law firms.
Pulsenmore has been chosen to participate in Israel's Healthcare AI Regulatory Sandbox Program, backed by the Israel Innovation Authority and the Ministry of Health. The company will receive funding to advance AI-based tools for its home ultrasound platform, aimed at improving efficiency in prenatal care.
RyboDyn has received $1.3 million from the U.S. Department of War to advance two antibody therapies for lung cancer, supporting preclinical development of programs based on targets discovered through its AI-powered CypherAtlas platform.
Sanyou Biopharmaceuticals has released GEOTA 1.0, a new digital computing platform within its SAI-DA program that simplifies access to AI-driven research tools for drug development.
Lucile Packard Children's Hospital Stanford has implemented R-Zero's Physical AI platform to optimize HVAC operations using real-time occupancy data. The system integrates with existing building management infrastructure to cut energy use by up to 40%.
Children’s Hospital of Philadelphia has been awarded up to $38.9 million over five years from ARPA-H’s THRIVE program to develop personalized gene editing therapies for rare liver-related genetic disorders.
Collectly has introduced its AI agent Billie and revenue cycle management platform on Epic's Connection Hub, offering healthcare providers automated patient billing, flexible payment plans, and 24/7 AI support without disrupting existing Epic workflows.
Movemedical has launched Ask Move AI, a mobile AI assistant designed to help medical device field representatives manage surgical case workflows using conversational interfaces on mobile devices.
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery have formed a joint initiative to support academic ventures in small molecule drug discovery, combining computational chemistry with experimental validation.
LifeLoop has launched Olia, an AI companion designed for life enrichment professionals in senior living communities. The tool supports staff with resident engagement, care continuity, and administrative tasks and will be available this fall.
NeuPT Technologies and VINSI.AI have launched ReadyOS, a platform that delivers objective physiological readiness assessments in under 90 seconds to guide clinical treatment decisions.
Pearl Health has raised $110 million to expand its AI platform that helps healthcare providers manage risk and improve care for Medicare patients. The raise includes equity financing led by Andreessen Horowitz and a credit facility from Trinity Capital.
Researchers from TReNDS Center and Amen Clinics report that machine learning models can differentiate individuals with schizophrenia from healthy controls using whole-brain SPECT imaging data.
Aureka has introduced OpenDDE, an open source biomolecular model designed to support AI applications in drug discovery. The model focuses on structural reasoning across proteins, nucleic acids, and small molecules and is available under the Apache-2.0 license.
Brook.ai and SRHO have announced a partnership to deploy Brook's AI remote care platform across more than 275 hospitals in 20 states, enabling continuous patient care beyond hospital settings.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
